ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec’s products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has more than 9,000 employees and does business in more than 100 countries. The company is owned by Nordic Capital and Avista Capital Partners.
The information contained in this section is considered accurate at the time of posting and may contain forward looking statements. The company maintains the archives of the material at the state it was distributed and does not update previously disseminated news releases or reports. By clicking on a document, you acknowledge that the information may no longer be accurate.
To sign up for email updates, enter your contact information below.